Delivery Order SPE2DB25D7067-SPE2DB25FSUTU

Award Date 3/21/25
Potential Completion Date 3/24/25
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,544.86 delivery order contract is for the supply of Dextroamphetamine-Amphetamine 5 mg tablets. The contract has a firm fixed price pricing type and an ultimate completion date of September 18, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Dextroamphetamine-Amphetamine 5 mg tablets. The contract has a ceiling value of $1,615.28 and a performance period through March 31, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth $999,999,999 through November 2026. This IDC serves as the primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,515.75 firm fixed price delivery order is for the supply of 4,567,268,740 units of 5 mg dextroamphetamine-amphetamine tablets. The contract has an ultimate completion date of February 14, 2025 and was awarded on February 13, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,298.51, is a Firm Fixed Price delivery order for the provision of 4558514394 - Dextroamphetamine-Amphetamine 10 mg tablets in 100-count bottles. The contract has an ultimate completion date of September 16, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,007.72 firm fixed-price delivery order is for the supply of 4,567,765,529 dextroamphetamine 10 mg tablets in 100-count bottles. The contract has an ultimate completion date of April 2, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,307.98, is for the delivery of 10 mg dextroamphetamine-amphetamine tablets in 100-count bottles. The contract is a firm fixed-price delivery order with an ultimate completion date of April 2, 2025. It is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $2,263.72 firm fixed-price delivery order contract is for the supply of 4,564,996,378 units of dextroamphetamine 10 mg tablets. The contract has a period of performance through June 26, 2024. AmerisourceBergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,026.75, is for the delivery of 4,567,426,586 units of 20 mg dextroamphetamine-amphetamine tablets. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of March 3, 2025. It is not designated as a set-aside contract. AmerisourceBergen holds a...
This federal contract award, valued at $1,926.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,285,738 units of dextroamphetamine-amphetamine 15 mg tablets, with a completion date of October 31, 2024. This is a delivery order contract with a firm fixed price pricing type. The contract is not designated with a set-aside requirement, indicating open...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,567,421,988 dextroamphetamine-amphetamine 10 mg tablets in 100-count bottles. The contract has a ceiling value of $1,053.12 and a completion date of March 3, 2025. It is a firm fixed-price delivery order contract type, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
  • SPE2DB25D7067
    Indefinite Delivery Contract
  • SPE2DB25D7067-SPE2DB25FSUTU
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,316.40, is a Firm Fixed Price Delivery Order for the supply of Dextroamphetamine-Amphetamine 5 mg tablets. The contract has an ultimate completion date of March 24, 2025.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

Generated 6/20/25, 9:51 AM